Remove Doctors Remove Pharmacy Remove Research
article thumbnail

Our abysmal health care system

World of DTC Marketing

First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. Patients and doctors are tired, and insurance companies are raising rates after two years of making a surplus because nobody went to the doctor during the pandemic. The result:?

Doctors 263
article thumbnail

Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy – Xtalks Life Science Podcast Ep. 163

XTalks

Dr. McLeod received his Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science and completed his Post-Doctoral Training at St Jude Children’s Research Hospital and the University of Glasgow. Dr. Roy is passionate about leveraging technology to amplify the impact of the pharmacist.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The social media problem for healthcare

World of DTC Marketing

The research that seems to be lacking is what online health seekers are doing due to researching online health information on social media. I believe too many are making treatment decisions because they don’t have a close relationship with their doctors; even if one person makes a wrong decision, that is one person too many.

Branding 224
article thumbnail

U.S. Pharmacy Chains Harm Patients With Medication Errors; NABP Appears Silent

Pharmacy Checkers

When you go to your local CVS and Walgreens – and other big pharmacy chains – are you getting the highest standard of care? Have these pharmacies gone rogue? Yet the National Association of Boards of Pharmacy (NABP) doesn’t seem to be paying much attention to medication errors at U.S. pharmacies. pharmacy industry.

article thumbnail

Is digital the future of medicine?

World of DTC Marketing

SUMMARY: McKinsey estimates that global digital-health revenues—from telemedicine, online pharmacies, wearable devices, and so on—will rise from $350bn last year to $600bn in 2024. Some 70% of American hospitals still fax and post patient records, and patients don’t have one record to share among all their doctors.

Medicine 201
article thumbnail

FTC launches probe into pharmacy benefit management sector

pharmaphorum

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). The post FTC launches probe into pharmacy benefit management sector appeared first on.

article thumbnail

Professionals and Patients Offer Mixed Views on Retail Pharmacy Chains’ Enthusiasm About Trials

ACRP blog

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.